Cancer Market Research Reports

Sort By :

TITLE Price Buy Now More options

Cervical Cancer Global Clinical Trials Review, H2, 2012 Cervical Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData''s clinical trial report, “Cervical Cancer Global Clinical Trials Review, H2, 2012" provides data on the Cervical Cancer clinical trial scenario. This report provides ele	$ 2500
Endometrial Cancer Global Clinical Trials Review, H2, 2012 Endometrial Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData''s clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H2, 2012" provides data on the Endometrial Cancer clinical trial scenario. This report pro	$ 2500
Esophageal Cancer Global Clinical Trials Review, H2, 2012 Esophageal Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData''s clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H2, 2012" provides data on the Esophageal Cancer clinical trial scenario. This report provid	$ 2500
Gastric Cancer Global Clinical Trials Review, H2, 2012 Gastric Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData''s clinical trial report, “Gastric Cancer Global Clinical Trials Review, H2, 2012" provides data on the Gastric Cancer clinical trial scenario. This report provides elemen	$ 2500
Peritoneal Cancer Global Clinical Trials Review, H2, 2012 Peritoneal Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData''s clinical trial report, “Peritoneal Cancer Global Clinical Trials Review, H2, 2012" provides data on the Peritoneal Cancer clinical trial scenario. This report provid	$ 2500
Thymus Cancer Global Clinical Trials Review, H2, 2012 Thymus Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData''s clinical trial report, “Thymus Cancer Global Clinical Trials Review, H2, 2012" provides data on the Thymus Cancer clinical trial scenario. This report provides elemental	$ 2500
Uterine Cancer Global Clinical Trials Review, H2, 2012 Uterine Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData''s clinical trial report, “Uterine Cancer Global Clinical Trials Review, H2, 2012" provides data on the Uterine Cancer clinical trial scenario. This report provides elemen	$ 2500
Vaginal Cancer Global Clinical Trials Review, H2, 2012 Vaginal Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData''s clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H2, 2012" provides data on the Vaginal Cancer clinical trial scenario. This report provides elemen	$ 2500
Ovarian Cancer Global Clinical Trials Review, H2, 2012 Ovarian Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData''s clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2012" provides data on the Ovarian Cancer clinical trial scenario. This report provides elemen	$ 2500
Pancreatic Cancer – Pipeline Review, H2 2012 Pancreatic Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Pancreatic Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic dev	$ 2500
Bone Cancer – Pipeline Review, H2 2012 Bone Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Bone Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for	$ 2000
Metastatic Hormone Refractory Prostate Cancer – Pipeline Review, H2 2012 Metastatic Hormone Refractory Prostate Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Metastatic Hormone Refractory Prostate Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline.	$ 2000
Cancer Cachexia – Pipeline Review, H2 2012 Cancer Cachexia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Cancer Cachexia - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic develop	$ 2000
Colorectal Cancer – Pipeline Review, H2 2012 Colorectal Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Colorectal Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic dev	$ 2500
Gastric Cancer – Pipeline Review, H2 2012 Gastric Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Gastric Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic developme	$ 2500
Skin Cancer – Pipeline Review, H2 2012 Skin Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Skin Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for	$ 2500
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H2 2012 Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2	$ 2000
Follicular Thyroid Cancer – Pipeline Review, H2 2012 Follicular Thyroid Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Follicular Thyroid Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the	$ 2000
Other Cancer – Pipeline Review, H2 2012 Other Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development f	$ 2000
Human papillomavirus (HPV) Associated Cancer – Pipeline Review, H2 2012 Human papillomavirus (HPV) Associated Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. T	$ 2000

First

Last

Live Chat Support

Connect With Us

Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option

Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: